News

A UB study identifies a potential therapeutic target against insulin resistance and type 2 diabetes

News | 11-05-2018

UB researchers have identified a key molecule in insulin resistance, a condition that favours the development of type 2 diabetes. The study, published in the science journal Metabolism. Clinical and Experimental, shows how the enzyme BACE1 and its product, soluble APPβ, are involved in the breaking out of the inflammatory process and insulin resistance. These results were obtained in mice and open the doors to the development of new drugs to treat this type of diabetes.

More


Share: